This is a template for an agreement or a will prepared by one of the partner in a partnership, wherein he declares to transfer his business interest to any other partner, after his death.
This white paper examines relationships of multiple causes of death as a function of factors available on the death certificate (demographics of decedent, place of death, type of certifier, disposal method, whether an autopsy was performed, and year of death).It concludes that multiple cause of death data provide a potentially...
There are certain bad events that can only occur once. Death is the obvious example: an individual's death is irreversible and unrepeatable. More mundane examples are bankruptcy, being struck off a professional register, and other discrete events. In addition there are other events that can in principle occur twice but...
Place of death is one indicator of the state of end-of-life care. This report examines trends in national death certificate data on place of death from 1980 to 1998. During these years the percentage of Americans dying as hospital inpatients decreased from approximately 54 percent to 41 percent. About 310,000...
This paper presents preliminary data on deaths for the year 2002 in the United States. U.S. data on deaths are shown by age, sex, race, and Hispanic origin. Death rates for 2002 are based on population estimates consistent with the April 1, 2000, census. Life expectancy at birth rose by...
This paper presents final data on U.S. deaths and death rates according to demographic and medical characteristics such as age, sex, Hispanic origin, race, marital status, educational attainment, injury at work, State of residence, and cause of death. Generally, mortality patterns in 2001 were consistent with long-term trends. The age-adjusted...
This paper presents preliminary data on deaths for the year 2001 in the United States. U.S. data on deaths are shown by age, sex, race, and Hispanic origin. Death rates for 2001 are based on population estimates consistent with the April 1, 2000, census. Data on life expectancy, leading causes...
The odds of being disabled for an extended period of time before age sixty-five are greater than the odds that you will die before age sixty-five. The younger you are, the greater the odds. Generally it is seen that a person 25 years of age has a 50% chance of...
This article will look at some of the issues that the clients and the lawyers should discuss if one wants the business to continue after the death. Before one meets with the lawyer to plan the estate he should sit down with the beneficiaries to try to answer some critical...
This paper presents final 2000 data on U.S. deaths and death rates according to demographic and medical characteristics such as age, sex, Hispanic origin, race, marital status, educational attainment, injury at work, State of residence, and cause of death. Trends and patterns in general mortality, life expectancy, and infant and...
This paper presents final 2000 data on the 10 leading causes of death in the United States by age, race, sex, and Hispanic origin. Leading causes of infant, neonatal, and post neonatal death are also presented. This paper supplements the annual report of final mortality statistics. In 2000 the 10...
From the executive summary: 'The recent spurt in crisis have stimulated people to think about the challenges organizations face in dealing with low-probability events that have catastrophic consequences. More specifically, there are certain bad events that can only occur once. Death is the clearest example: an individual's death is irreversible...
This paper describes strategies for conducting pregnancy-related or maternal mortality surveillance in the United States. This surveillance is an ongoing process of identifying pregnancy-related deaths, reviewing the factors that led to those deaths, analyzing and interpreting the information gathered, and acting on the results so as to reduce such deaths...
This paper presents preliminary data on deaths for the year 2000 in the United States. U.S. data on deaths are shown by age, sex, race, and Hispanic origin. Data on life expectancy, leading causes of death, and infant mortality are also presented. The age-adjusted death rate in 2000 for the...
This paper presents final data on U.S. deaths and death rates according to demographic and medical characteristics. Trends and patterns in general mortality, life expectancy, and infant and maternal mortality are also described. A previous paper presented preliminary mortality data for 1999. Generally, mortality continued long-term trends. Life expectancy in...
This paper presents preliminary data for 1999 on deaths in the United States. U.S. data on deaths are shown by age, sex, race, and Hispanic origin. Data on life expectancy, leading causes of death, and infant mortality are also presented. In 1999 the age-adjusted death rate for the United States...
Organizational death is as necessary a part of our economic system as organizational birth. We need a Death Valley that has equal status with Silicon Valley. Most organizations engage in both value-creating and value-destroying activities. This is because trial-and-error is an essential part of value generation, and not all activities...
This paper presents final 1998 data on U.S. deaths and death rates according to demographic and medical characteristics such as age, sex, race, Hispanic origin, marital status, educational attainment, injury at work, State of residence, and cause of death. Trends and patterns in general mortality, life expectancy, and infant and...
By James Regan SYDNEY (Reuters UK) - BHP Billiton suspended all its iron ore mining in Australia on Friday, shutting in a third of the country's production after the second mine worker death in the past 10 days, raising broader safety concerns in its mines. A...
Amylin's recent woes with its new diabetes drug, Byetta—six people have died, possibly as a result of taking the drug—raises a crucial question that has long vexed companies and patients about the medications we take for what ails us. What is an acceptable trade-off between drugs...